145 related articles for article (PubMed ID: 26975632)
1. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
3. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
4. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.
Tang S; Yang G; Meng Y; Du R; Li X; Fan R; Zhao L; Bi Q; Jin J; Gao L; Zhang L; Li H; Fan M; Wang Y; Wu K; Liu J; Fan D
Cancer Biol Ther; 2010 Jan; 9(2):88-95. PubMed ID: 19901563
[TBL] [Abstract][Full Text] [Related]
7. Gankyrin promotes the proliferation of human pancreatic cancer.
Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
9. Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis.
Lacher MD; Pincheira R; Zhu Z; Camoretti-Mercado B; Matli M; Warren RS; Castro AF
Oncogene; 2010 Dec; 29(50):6543-56. PubMed ID: 20818424
[TBL] [Abstract][Full Text] [Related]
10. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
11. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
[TBL] [Abstract][Full Text] [Related]
12. Rab1A is an mTORC1 activator and a colorectal oncogene.
Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
[TBL] [Abstract][Full Text] [Related]
13. Association of gankyrin and stemness factor expression in human colorectal cancer.
Mine H; Sakurai T; Kashida H; Matsui S; Nishida N; Nagai T; Hagiwara S; Watanabe T; Kudo M
Dig Dis Sci; 2013 Aug; 58(8):2337-44. PubMed ID: 23508981
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
[TBL] [Abstract][Full Text] [Related]
15. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer.
Sakurai T; Komeda Y; Nagai T; Kamata K; Minaga K; Yamao K; Takenaka M; Hagiwara S; Watanabe T; Nishida N; Kashida H; Nakagawa K; Kudo M
Digestion; 2019; 100(3):192-200. PubMed ID: 30513515
[TBL] [Abstract][Full Text] [Related]
17. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.
García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M
Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907
[TBL] [Abstract][Full Text] [Related]
18. Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells.
Gao Y; Gartenhaus RB; Lapidus RG; Hussain A; Zhang Y; Wang X; Dan HC
Mol Cancer Res; 2015 Dec; 13(12):1602-14. PubMed ID: 26374334
[TBL] [Abstract][Full Text] [Related]
19. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
[TBL] [Abstract][Full Text] [Related]
20. Odontogenic ameloblast-associated protein (ODAM) inhibits human colorectal cancer growth by promoting PTEN elevation and inactivating PI3K/AKT signaling.
Yu M; Mu Y; Qi Y; Qin S; Qiu Y; Cui R; Zhong M
Biomed Pharmacother; 2016 Dec; 84():601-607. PubMed ID: 27694004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
